Rejected at 2:44 a.m. Apr, 29, 2024 ] by Cameron
Author: a.aniekwe
Co-authors: herstein.jacob
Related Note: 1482374341463
Rationale for change

Nuance between severe and mild is tested
Source: UWorld - Step 2 14431

Rejection reason

comments

Text Text
Extra
Lecture Notes
Empty field
Missed Questions
Empty field
Pathoma
Empty field
Boards and Beyond
Empty field
First Aid
Sketchy
Sketchy 2
Sketchy Extra
Empty field
Picmonic
Empty field
Pixorize
Physeo
Bootcamp
OME
Additional Resources
Empty field
One by one
Empty field
#AK_Step1_v12::#UWorld::COMLEX::26034 #AK_Step2_v12::#SketchyIM::10_Gastroenterology::Retired_Lesson::02_Benign_Colorectal_Disorders::02_Inflammatory_Bowel_Disease_2_Ulcerative_Colitis_Clinical_Case_[OLD_VERSION] #AK_Step1_v12::#FirstAid::09_Gastrointestinal::04_Pathology::13_Inflammatory_bowel_diseases::*Treatment #AK_Other::AnKing_Image::Mujeeb::Inflammatory_Bowel_Diseases::Detailed #AK_Step1_v12::#UWorld::Step::14947 #AK_Step1_v12::#OME::04_Organ_Systems::03_Gastrointestinal::01_Digestion_&_Absorption::14_Inflamed_Bowel #AK_Step1_v12::#FirstAid::11_Musculoskeletal_Skin_and_Connective_Tissue::04_Pharm::10_TNF-alpha_inhibitors::*Infliximab #PANCE::EOR::EM #AK_Step1_v12::#FirstAid::02_Immunology::04_Immunosuppressants::03_Therapeutic_antibodies #AK_Step2_v12::#SketchyIM::10_Gastroenterology::03_Colon_Disorders::02_Inflammatory_Bowel_Disease:_Crohn's_Disease_&_Ulcerative_Colitis #PANCE::GI::colorectal_disorders #AK_Step1_v12::#Pathoma::10_GI::07_Inflammatory_Bowel_Disease #AK_Step1_v12::^Systems::GI::pathology #PANCE::EOR::IM #AK_Step1_v12::#SketchyPharm::03_Blood_&_Inflammation::03_Anti-inflammatory::04_TNF_Inhibitors #AK_Step1_v12::#Pixorize::02_Immunology::05_Cytokines::01_TNF-alpha #AK_Other::Only_Step_1 #AK_Step1_v12::#UWorld::Step::14805 #PANCE::EOR::Surgery #AK_Step1_v12::#Bootcamp::Gastroenterology::09_Large_Intestine::04_Crohn_Disease #AK_Step1_v12::#Physeo::^physeo_image_update #AK_Step1_v12::#Pixorize::03_Pharmacology::13_Musculoskeletal_Pharm::12_TNF_Inhibitors_((Infliximab/Adalimumab/Certolizumab/Golimumab) #AK_Step2_v12::#SketchyIM::10_Gastroenterology::Retired_Lesson::02_Benign_Colorectal_Disorders::01_Inflammatory_Bowel_Disease_1_Crohn's_Disease_Clinical_Case_[OLD_VERSION] #AK_Step1_v12::#DirtyMedicine::09_Gastrointestinal::02_Crohn's_vs._Ulcerative_Colitis #AK_Step1_v12::#UWorld::COMLEX::25945 #AK_Other::AnKing_Image::!Subjects::Gastroenterology::Inflammatory_Bowel_Diseases #AK_Step1_v12::#FirstAid::02_Immunology::04_Immunosuppressants::03_Therapeutic_antibodies::01_Autoimmune_disease_therapy::*Adalimumab #AK_Step1_v12::#Physeo::11_Pathology::06_Gastrointestinal_Pathology::07_Inflammatory_Bowel_Disease #AK_Step1_v12::#NBME::31 #AK_Step1_v12::#AMBOSS::lhavV4 #AK_Step1_v12::#Low/HighYield::2-RelativelyHighYield #AK_Step1_v12::#USMLERx::2706.18 #AK_Step1_v12::#OME::Clinical::04_Organ_Systems::03_Gastrointestinal::01_Digestion_&_Absorption::14_Inflamed_Bowel #AK_Step2_v12::#AMBOSS::gw0FRR #AK_Step2_v12::#UWorld::Step::14431 #AK_Step1_v12::#FirstAid::11_Musculoskeletal_Skin_and_Connective_Tissue::04_Pharm::10_TNF-alpha_inhibitors::*Adalimumab #AK_Step2_v12::#B&B::06_GI::04_Intestines::04_Inflammatory_Bowel_Disease::Extra #AK_Step1_v12::#Bootcamp::Musculoskeletal::15_Pharmacology::07_TNF_Alpha_Inhibitors_And_Monoclonal_Antibodies #AK_Other::#AK_Original_Decks::Step_1::Zanki_Step_Decks::Zanki_GI::GI_Pathology #AK_Step1_v12::#Physeo::09_Pharm::09_Musculoskeletal::09_TNF-alpha_Inhibitors #AK_Step2_v12::#UWorld::COMLEX::102612 #AK_Step1_v12::#FirstAid::02_Immunology::04_Immunosuppressants::03_Therapeutic_antibodies::01_Autoimmune_disease_therapy::*Infliximab #AK_Step1_v12::#FirstAid::09_Gastrointestinal::04_Pathology::13_Inflammatory_bowel_diseases::*Basics #AK_Step1_v12::#Bootcamp::GastroenterologyV2::09_Large_Intestine::05_Ulcerative_Colitis